- Home
- YMAB vs SLND Comparison
YMAB vs SLND Comparison
Compare YMAB & SLND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YMAB
- SLND
- Stock Information
- Founded
- YMAB 2015
- SLND 1900
- Country
- YMAB United States
- SLND United States
- Employees
- YMAB N/A
- SLND N/A
- Industry
- YMAB Biotechnology: Pharmaceutical Preparations
- SLND Military/Government/Technical
- Sector
- YMAB Health Care
- SLND Industrials
- Exchange
- YMAB Nasdaq
- SLND Nasdaq
- Market Cap
- YMAB 192.4M
- SLND 175.8M
- IPO Year
- YMAB 2018
- SLND N/A
- Fundamental
- Price
- YMAB $4.36
- SLND $4.75
- Analyst Decision
- YMAB Buy
- SLND Strong Buy
- Analyst Count
- YMAB 11
- SLND 1
- Target Price
- YMAB $17.55
- SLND $5.00
- AVG Volume (30 Days)
- YMAB 202.0K
- SLND 79.4K
- Earning Date
- YMAB 08-11-2025
- SLND 08-11-2025
- Dividend Yield
- YMAB N/A
- SLND N/A
- EPS Growth
- YMAB N/A
- SLND N/A
- EPS
- YMAB N/A
- SLND N/A
- Revenue
- YMAB $88,658,000.00
- SLND $931,568,000.00
- Revenue This Year
- YMAB N/A
- SLND $3.76
- Revenue Next Year
- YMAB $15.15
- SLND $1.08
- P/E Ratio
- YMAB N/A
- SLND N/A
- Revenue Growth
- YMAB 4.92
- SLND N/A
- 52 Week Low
- YMAB $3.55
- SLND $1.85
- 52 Week High
- YMAB $16.11
- SLND $4.90
- Technical
- Relative Strength Index (RSI)
- YMAB 45.29
- SLND 73.96
- Support Level
- YMAB $4.10
- SLND $4.31
- Resistance Level
- YMAB $4.62
- SLND $4.62
- Average True Range (ATR)
- YMAB 0.29
- SLND 0.26
- MACD
- YMAB -0.04
- SLND 0.06
- Stochastic Oscillator
- YMAB 20.73
- SLND 97.03
About YMAB Y-mAbs Therapeutics Inc.
Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.
About SLND Southland Holdings Inc.
Southland Holdings Inc is an infrastructure construction company in North America. The company's infrastructure projects range from water conveyance systems and tunnels to long-span bridges and vertical structures.